Celsion

$0.535
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.0093 (+1.77%) As of 9:46 AM EST today

Why Robinhood?

You can buy or sell Celsion and other stocks, options, and ETFs commission-free!

About CLSN

Celsion Corporation Common Stock, also called Celsion, is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm engages in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ. The listed name for CLSN is Celsion Corporation Common Stock.

CEO

Michael H. Tardugno

Employees

Headquarters

Lawrenceville, New Jersey

Founded

1982

Market Cap

19.68M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

607.46K

High Today

$0.54

Low Today

$0.526

Open Price

$0.54

Volume

96.54K

52 Week High

$6.50

52 Week Low

$0.4305

Collections

Technology

Health

Medical

Research And Development

Pharmaceutical

Cancer Prevention

North America

CLSN Earnings

-$0.32

-$0.21

-$0.11

$0.00

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Estimated

-$0.13 per share

Actual

-$0.17 per share

Replay Earnings Call